CCR Podcast 1 - Paul Young on ICU-ROX 


Photo Paul Young

ICU-ROX is a phase 2b, parallel group, multi-centre, randomised, single blinded clinical trial comparing liberal with conservative oxygen therapy in mechanically ventilated adults in the Intensive Care Unit. Its chief investigator is Dr Paul Young, from Wellington, New Zealand, who talks with Rob Mac Sweeney about both ICU-ROX and the REACTOR trial.

Further details: